key: cord-1005871-az9nug6p authors: Valente, Paola; Iarossi, Giancarlo; Federici, Matteo; Petroni, Sergio; Palma, Paolo; Cotugno, Nicola; De Ioris, Maria A.; Campana, Andrea; Buzzonetti, Luca title: Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report date: 2020-06-09 journal: J AAPOS DOI: 10.1016/j.jaapos.2020.05.002 sha: a6e484d28090fa52d811b920a6fce3c5f7b88abb doc_id: 1005871 cord_uid: az9nug6p Abstract Purpose To evaluate ocular manifestations and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) prevalence in the tears of children with coronavirus disease 2019 (COVID-19). Methods A total of 27 pediatric patients with confirmed COVID-19 infection hospitalized from March 16 to April 15, 2020, at the Bambino Gesù Children’s Hospital were enrolled in the study. At admission, all patients showed ocular manifestations. Reverse transcriptase–polymerase chain reaction from nasopharyngeal and conjunctival swabs were performed every 2-3 days before discharge. Results Of the 27 patients, 4 (15%) were asymptomatic, 15 (56%) showed respiratory symptoms, and 8 (30%) had gastrointestinal symptoms. At admission, nasopharyngeal swabs were positive for COVID-19 in all patients; on the second swabs, 7 children (26%) tested negative, and 20 remained positive for COVID-19. Ocular manifestations consistent with mild viral conjunctivitis were observed in 4 patients (15%). At first conjunctival swab, 3 patients (11%), 1 symptomatic and 2 asymptomatic for ocular infection, had positive findings for COVID-19; 2 became negative on the second test and 1 on the third. Conclusions In our study cohort, ocular manifestations of COVID-19 seem to have had a milder clinical course in pediatric patients than in adults. Despite the low prevalence and rapid regression of viral presence in the conjunctiva, SARS-CoV-2 transmission through tears may be possible, even in patients without apparent ocular involvement. Since its onset in December 2019 in Wuhan (Hubei Province, China) the coronavirus disease 2019 (COVID- 19) has quickly spread across the globe, causing a global pandemic, according to the World Health Organization (WHO). 1 The pathogen of COVID-19 is a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can cause multiple system infections but mainly respiratory tract infections, such as severe acute respiratory syndrome. 2, 3 The most common signs and symptoms include fever, cough, fatigue, myalgia, dyspnea, diarrhea. 4, 5 Compared with adults, children with COVID-19 seem to have lower incidence, shorter course of disease, and a more favorable clinical presentation and prognosis. 6, 7 The transmission route of this novel coronavirus (SARS-CoV-2) remains unclear, and most authors report that it occurs mainly through direct contact or respiratory droplets. 4 Previous studies have investigated the viral presence in tears of patients with SARS-CoV-1 and SARS-CoV-2, reporting controversial results. [8] [9] [10] [11] [12] [13] [14] All of these studies were performed in adult patients. In this study we evaluated ocular involvement and the SARS-CoV-2 virus shedding in tears of 27 pediatric patients admitted to the Bambino Gesù Children's Hospital (BGCH) COVID Center in order to better understand the pathogenicity of SARS-CoV-2 in children's eyes. This study was approved by the Bambino Gesù Children's Hospital Ethics Committee and adhered to the tenets of the Declaration of Helsinki. Informed consent to the procedure was obtained for each patient. This prospective observational case series study included 27 pediatric patients (7 females; mean age, 84 months; age range, 8 days to 210 months) with infection confirmed by nasopharyngeal swab COVID-19 nucleic acid test. All patients were hospitalized from March 16 to April 15, 2020, at BGCH in the COVID-dedicated inpatient service created for the management of the SARS-COV-2 pandemic. Clinical data, including demographic information, contact history, clinical symptoms, and laboratory findings were reviewed and analyzed. Ocular symptoms and signs were also recorded. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) tests (GeneXpert, Cepheid, Sunnyvale, CA; 250 copies/mL sensitivity, 100% specificity) from nasopharyngeal and conjunctival swabs were performed on admission and repeated every 2-3 days before discharge; the microbiological surveillance was discontinued after two consecutive negative samples. Swabs to collect tears and conjunctival secretions were performed from the lower eyelid fornix without topical anesthesia to avoid possible contamination of the specimen. Follow-up for each patient continued through April 15, 2020. The laboratory tests were performed in accordance with the guidelines and in laboratories identified for COVID-19 detection by the Italian Health Ministry. Clinical and demographic data of patients are summarized in Table 1 . On admission, 23 patients were symptomatic: 15 patients (56%) showed respiratory symptoms (cough or dyspnea with or without fever), and 8 patients (30%) had gastrointestinal symptoms (vomiting and/or diarrhea with or without fever). No systemic symptoms were detected in 3 newborns whose mothers were infected. Average time from symptoms to admission was 7 days (range, 0-19). On hospital admission, nasopharyngeal swab to COVID-19 tested positive in all patients. The epidemiology and clinical course of SARS-CoV-2 seems to differ in childhood compared with adults, with a mean lower incidence and milder symptoms in the pediatric population. 6, 16, 17 Several reports have investigated ocular involvement in adult patients with COVID-19 infection. 8 Another issue is the difference between nasopharyngeal and ocular viral shedding trends. In our patients, the conjunctival swab became negative in all patients much sooner than did the nasopharyngeal swab. In most of the cases, patients with persistent positive nasopharyngeal swab over days maintained a negative conjunctival swab, confirming that the viral load in the tear fluid is less than in other biological specimens and that the eye is relatively preserved in comparison with other organs. In consideration of these findings, conjunctival swab should not be considered a valuable diagnostic test of COVID-19, particularly in children. Nevertheless, despite the low prevalence and rapid regression of viral presence in the conjunctiva, transmission through tears is theoretically possible, even if the ocular contagious phase in children seems to be relatively brief. This contrasts with the evidence of long viral persistence and replication in conjunctiva recently reported in adults, but it might be explained by the milder manifestation of the disease in the pediatric population. Of the children hospitalized for COVID-19, identification of SARS-COV-2 RNA from ocular secretions was uncommon. Of the 3 children (11%) found to have SARS-COV-2 RNA in tears, 2 were without ocular signs or symptoms and 1 had mild conjunctivitis. PCR-based shedding of SARS-CV-2 tended to clear faster from tears than from oropharyngeal secretions (median, 4 vs 8 days), although the ranges were wide, with sizable overlap (2-17 vs 3-6 days, resp.). This study has some limitations, including its relatively small sample size. Another is the uncertainty of the efficacy of RT PCR as a technique for diagnosing SARS-CoV-2 in tears. 19, 20 False-negative results, usually due to sample contamination or insufficient sample concentration for RT PCR virus detection, could not be ruled out, mainly in children whose poor compliance may hinder the collection of tears and conjunctival secretion. To decrease false negatives, we repeated the test at least twice for each patient before discharge. In conclusion, our preliminary data confirms the relatively milder symptoms experienced by pediatric patients and supports the possible presence of viral load in tears and conjunctival secretion. Thus, although pediatric ocular manifestations in COVID-19 seem to be mild, there is still a risk of transmission. Although SARS-CoV-2 prevalence is low in tears and may disappear, potential ocular transmission must be considered by clinicians treating pediatric patients, in whom disease effects may be milder and eye involvement mostly asymptomatic but hand-to-face contact is common. World Health Organization Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. Epub ahead of print The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak A Review of coronavirus disease 2019 (COVID-19) Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults Epidemiology and clinical features of coronavirus disease 2019 in children The severe acute respiratory syndrome coronavirus in tears Can the coronavirus disease 2019 (COVID-19) affect the eyes? a review of coronaviruses and ocular implications in humans and animals SARS-CoV-2 Isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection 2019 nCoV transmission through the ocular surface must not be ignored Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS CoV 2 infection Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19 COVID-19 in children: more than meets the eye Severe acute respiratory syndrome coronavirus pathogenesis, disease and vaccines: an update Middle East respiratory syndrome coronavirus disease is rare in children: an update from Saudi Arabia Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients The severe acute respiratory syndrome coronavirus in tears A meta analysis to evaluate the effectiveness of real time PCR for diagnosing novel coronavirus infections